MERRIMACK PHARMACEUTICALS INC Debt Conversion, Converted Instrument, Amount
MERRIMACK PHARMACEUTICALS INC reported Debt Conversion, Converted Instrument, Amount of $64.21 million for the 6-month period ending 2016-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2017-08-09
- MERRIMACK PHARMACEUTICALS INC debt conversion, converted instrument, amount for fiscal 2013 was $51.88M.
| Period end | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|
| 2016-06-30 | $64.21M 10-Q · filed 2017-08-09 | |
| 2013-12-31 | $51.88M 10-K · filed 2016-02-26 |